Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007
Real Estate	214.00M	267.00M
Real Estate Growth	-19.85%	-1.11%
Pharmaceuticals	48.40B	44.09B
Pharmaceuticals Growth	9.77%	-6.58%
Total	48.61B	44.36B
Total Growth	9.59%	-6.55%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007
Japan	62.31B	60.56B	55.41B	48.61B	44.36B
Japan Growth	2.88%	9.31%	13.98%	9.59%	-6.55%
Total	62.31B	60.56B	55.41B	48.61B	44.36B
Total Growth	2.88%	9.31%	13.98%	9.59%	-6.55%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error